June 22, 2020
The emergence of COVID-19 has forced clinical researchers to endure major setbacks related to existing academic and industry-sponsored clinical trials. Recognizing these constraints, the ACC convened a focused Heart House Roundtable on May 29 to better understand the pandemic’s implications for ongoing and future cardiovascular research. The series brought together stakeholders from across the health care spectrum to focus on key questions needed for front-line clinicians, the larger cardiovascular treatment infrastructure and how it needs to develop as the pandemic progresses. The Heart House Roundtable is part of a larger, comprehensive COVID-19 science and education effort by the College. The next Roundtable in this series will address telehealth, which has quickly emerged on the scene, but is an area where additional guidance is needed.